JP5162080B2 - 乳腺炎治療 - Google Patents

乳腺炎治療 Download PDF

Info

Publication number
JP5162080B2
JP5162080B2 JP2004559809A JP2004559809A JP5162080B2 JP 5162080 B2 JP5162080 B2 JP 5162080B2 JP 2004559809 A JP2004559809 A JP 2004559809A JP 2004559809 A JP2004559809 A JP 2004559809A JP 5162080 B2 JP5162080 B2 JP 5162080B2
Authority
JP
Japan
Prior art keywords
prednisolone
treatment
mastitis
cows
intramammary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2004559809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514642A (ja
Inventor
コツクス，ペーテル・ヘラルドウス・フランシスクス
ローハイス，ヨセフ・アントニウス・クレメンス・マリア
ヘンセン，セルマ・マリアンネ
Original Assignee
インターベツト・インターナシヨナル・ベー・ベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32524018&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5162080(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by インターベツト・インターナシヨナル・ベー・ベー filed Critical インターベツト・インターナシヨナル・ベー・ベー
Publication of JP2006514642A publication Critical patent/JP2006514642A/ja
Application granted granted Critical
Publication of JP5162080B2 publication Critical patent/JP5162080B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2004559809A 2002-12-16 2003-12-10 乳腺炎治療 Expired - Lifetime JP5162080B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02080265.8 2002-12-16
EP02080265 2002-12-16
PCT/EP2003/014051 WO2004054538A1 (en) 2002-12-16 2003-12-10 Mastitis treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012197468A Division JP2013035845A (ja) 2002-12-16 2012-09-07 乳腺炎治療

Publications (2)

Publication Number Publication Date
JP2006514642A JP2006514642A (ja) 2006-05-11
JP5162080B2 true JP5162080B2 (ja) 2013-03-13

Family

ID=32524018

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004559809A Expired - Lifetime JP5162080B2 (ja) 2002-12-16 2003-12-10 乳腺炎治療
JP2012197468A Pending JP2013035845A (ja) 2002-12-16 2012-09-07 乳腺炎治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012197468A Pending JP2013035845A (ja) 2002-12-16 2012-09-07 乳腺炎治療

Country Status (9)

Country Link
US (1) US7812009B2 (en:Method)
EP (1) EP1585497B1 (en:Method)
JP (2) JP5162080B2 (en:Method)
AT (1) ATE390124T1 (en:Method)
AU (1) AU2003290015A1 (en:Method)
CA (1) CA2508022C (en:Method)
DE (1) DE60320034T2 (en:Method)
ES (1) ES2300634T3 (en:Method)
WO (1) WO2004054538A1 (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013035845A (ja) * 2002-12-16 2013-02-21 Intervet Internatl Bv 乳腺炎治療

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
ES2346573T3 (es) * 2005-10-29 2010-10-18 Intervet International Bv Composiciones de cefquinoma y metodos para su uso.
WO2008025773A1 (en) * 2006-08-30 2008-03-06 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
CN101148451A (zh) * 2007-05-16 2008-03-26 好维股份有限公司 一种口腔药物及口腔护理用品
WO2011074992A1 (en) * 2009-12-15 2011-06-23 Dec International Nz Limited Treatment composition and method
EP2510944A1 (en) * 2011-04-15 2012-10-17 National University of Ireland, Galway Treatment of bacterial infections
JP2014516950A (ja) * 2011-05-12 2014-07-17 インターベット インターナショナル ベー． フェー． 乳腺炎の治療
JP6271443B2 (ja) 2012-02-27 2018-01-31 バイエル・ニュージーランド・リミテッド 制御放出組成物およびその使用方法
EP3031464B1 (en) 2013-05-17 2020-04-01 Asahi Calpis Wellness Co., Ltd. Preventive or therapeutic agent for ruminant animal mastitis
JP2018525985A (ja) * 2015-07-29 2018-09-13 ジーナス ピーエルシー 乳生産量を改善するための雌牛の育種方法
ES2985441T3 (es) 2018-07-30 2024-11-05 Virbac Utilización novedosa de glucocorticoides para el tratamiento de infecciones microbianas epiteliales de un órgano que contiene fluidos con un orificio exterior natural en mamíferos
CN113209014A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效硫酸头孢喹肟混悬注射液及其制备工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU504840B2 (en) 1975-09-09 1979-11-01 Takeda Chemical Industries Ltd Medicinal compositions
JPS5234914A (en) * 1975-09-09 1977-03-17 Takeda Chem Ind Ltd Method and composition for preventing failing of milk secretion of live stocks
JPS52110816A (en) * 1976-03-15 1977-09-17 Takeda Chem Ind Ltd Medicines
ES2300634T3 (es) 2002-12-16 2008-06-16 Intervet International Bv Tratamiento de mastitis con una combinacion de prednisolona con cefalosporina.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013035845A (ja) * 2002-12-16 2013-02-21 Intervet Internatl Bv 乳腺炎治療

Also Published As

Publication number Publication date
US7812009B2 (en) 2010-10-12
WO2004054538A1 (en) 2004-07-01
AU2003290015A1 (en) 2004-07-09
JP2006514642A (ja) 2006-05-11
DE60320034T2 (de) 2009-05-14
ATE390124T1 (de) 2008-04-15
CA2508022C (en) 2012-01-31
JP2013035845A (ja) 2013-02-21
DE60320034D1 (de) 2008-05-08
EP1585497A1 (en) 2005-10-19
US20060058273A1 (en) 2006-03-16
EP1585497B1 (en) 2008-03-26
CA2508022A1 (en) 2004-07-01
ES2300634T3 (es) 2008-06-16

Similar Documents

Publication Publication Date Title
JP2013035845A (ja) 乳腺炎治療
CN1119170C (zh) 细球菌素抗生素在制备治疗或预防乳腺炎的药物中的用途
JP2006528705A (ja) ウシおよびブタにおける感染を処置するための組成物
JPH1053533A (ja) 敗血症およびａｒｄｓの治療法
Nickerson Resistance mechanisms of the bovine udder: new implications for mastitis control at the teat end
AU677786B2 (en) Lysozyme dimer and compositions containing the same
IE903805A1 (en) Method for the Prevention and Treatment of Bovine Mastitis
JP2000510842A (ja) 全身性細菌疾患の治療のための抗菌剤の局所投与
IE51846B1 (en) Pharmaceutical preparation for veterinary use and an appliance containing it
Janosi et al. The use of the dry cow therapy in the control of bovine mastitis
CN110917128A (zh) 一种替米考星注射液
JP2012517472A (ja) 縮小ゲノム細菌を含む敗血症治療用組成物
EP0548558A2 (en) Compositions containing surfactants as potentiating agents for the treatment of mammalian diseases
KR102203849B1 (ko) 동물용 복합 항생제 조성물
JP2001511451A (ja) 家畜乳房炎の治療のためのリファマイシン誘導体の使用
JP5439638B2 (ja) 乳房炎治療剤
EP4267146B1 (en) An orthosomycin antimicrobial compound for use in methods of treating mastitis
CN104840420A (zh) 一种用于奶牛的硫酸头孢喹肟子宫注入剂及其制备方法
EP0238207A1 (en) Bactericidal mixtures
CA2079328C (en) Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof
AU2007291308A1 (en) Pharmaceutical compositions comprising cefquinome
KR20230045320A (ko) 데커시놀 안젤레이트를 유효성분으로 포함하는 메티실린 내성 황색 포도상 구균 감염에 의한 패혈증 완화 및 치료용 조성물
CN110917129A (zh) 一种制备替米考星注射液的方法
JP2004292462A (ja) ウシ乳房炎の予防剤および予防方法
OSUGI et al. Clinical study on Cefotetan (CTT) in the field of oral surgeryThe administration of CTT to prevent postoperative infection

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060807

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20061222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100216

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100510

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100816

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110412

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110419

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120907

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120910

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20121003

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121211

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121217

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5162080

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151221

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term